Stay updated on Tideglusib in Congenital Myotonic Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page.

Latest updates to the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedA site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check20 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study record content. This indicates an access or server issue that prevents viewing the study details on this page.SummaryDifference19%

- Check69 days agoChange DetectedThe page adds a funding reference (2016 NIH Grant/Contract) and updates the site revision tag to v3.6.6, reflecting funding attribution and a software version change.SummaryDifference0.1%

Stay in the know with updates to Tideglusib in Congenital Myotonic Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page.